# Molecular Partners AG: Form 20-F for the period ended Dec 31, 2024

- Company: [Molecular Partners AG](/companies/moln.md) (CIK 1745114)
- Form: 20-F
- Filed: 2025-03-06
- Accepted by EDGAR: Mar 6, 2025, 16:00 ET
- Period: 2024-12-31
- Accession: 0001745114-25-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745114/000174511425000009/moln-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745114/000174511425000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | CHF 5.0m | ifrs-full:Revenue |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −CHF 61.2m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | CHF 2.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −CHF 54.0m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | −CHF 1.59 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −CHF 1.59 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −CHF 59.2m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | CHF 705.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2024-12-31 | CHF 63.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2024-12-31 | CHF 154.3m | ifrs-full:CurrentAssets |
| Total assets | at 2024-12-31 | CHF 158.5m | ifrs-full:Assets |
| Current liabilities | at 2024-12-31 | CHF 10.8m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2024-12-31 | CHF 16.9m | ifrs-full:Liabilities |
| Shareholders' equity | at 2024-12-31 | CHF 141.6m | ifrs-full:Equity |
| Shares outstanding | at 2024-12-31 | 40,363,095 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745114/000174511425000009/moln-20241231.htm

Filed Mar 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001745114-25-000009. Last ingested by Listed: Oct 29, 2026, 06:05 ET. No prices; not investment advice.
